Evaluation of selenium, zinc and copper levels related to GST genetic polymorphism in lung cancer patients

Trace Elements and Electrolytes

Volumn 22, Issue 1, 2005, Pages 23-32

  Reszka, E ^a   Wasowicz, W ^a   Gromadzinska, J ^a   Winnicka, R ^a   Szymczak, W ^a  

^a NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

Author keywords

Copper; Glutathione s transferase; Lung cancer; Selenium zinc

Indexed keywords

COPPER; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE M3; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; SELENIUM; UNCLASSIFIED DRUG; ZINC;

ADULT; AGED; ALLELE; ARTICLE; CANCER INCIDENCE; CANCER PATIENT; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; COPPER BLOOD LEVEL; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; LUNG CANCER; LUNG CARCINOGENESIS; MAJOR CLINICAL STUDY; MALE; POLAND; PRIORITY JOURNAL; SELENIUM BLOOD LEVEL; TRACE METAL BLOOD LEVEL; ZINC BLOOD LEVEL;

EID: 13844275136     PISSN: 09462104     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (78)

1. Agarwal RP, Henkin RL 1985 A simple method for simultaneous estimation of zinc and copper in erythrocytes. Biol Trace Elem Res 7: 199-208
2. Alejos MS, Diaz Romero F, Diaz Romero C 2000 Selenium and cancer: some nutritional aspects. Nutrition 16: 376-383
3. Arteel GE, Sies H 2001 The biochemistry of selenium and the glutathione system. Environ Toxicol Pharmacol 10: 153-158
4. Bay BH, Tan BKH, Sit KH, Hsu A 1996 Cytochrome P450 content and ultrastructural changes in liver of zinc-treated C57/6J mice. Pharmacol Res 34: 93-97
5. Bayoumy KE 2000 The protective role of selenium on genetic damage and on cancer. Mutat Res 475: 123-139
6. Behne D, Kyriakopoulos A 2001 Mammalian selenium-containing proteins. Annu Rev Nutr 21: 453-473
7. Brigelius-Flohe R 1999 Tissue-specific functions of individual glutathione peroxidases. Free Radic Biol Med 27: 951-965
8. Brooks JD, Metter EJ, Chan DW, Sokoll LJ, Landis P, Nelson WG, Muller D, Andres R, Carter HB 2001 Plasma selenium level before diagnosis and the risk of prostate cancer development. J Urol 166: 2034-2038
9. Cabre M, Camps J, Ferre N, Paternain JL, Joven J 2001 The antioxidant and hepato-protective effects of zinc are related to hepatic cytochrome P450 depression and metallothionein induction in rats with experimental cirrhosis. Int J Vitam Nutr Res 71: 229-236
10. Carrasco J, Penkowa M, Hadberg H, Molinero A, Hidalgo J 2000 Enhanced seizures and hippocampal neurodegeneration following kainic acid-induced seizures in metallothionein-I+II-deficient mice. Eur J Neurosci 12: 2311-2322
11. 1 albumin adduct level with plasma selenium level and genetic polymorphisms of glutathione S-transferase M1 and T1. Nutr Cancer 38: 179-185
12. Dabek JT, Hyvonen-Dabek M, Härkönen M, Adlercreutz H 1992 Evidence for increased noneeruloplasmin copper in early-stage human breast cancer serum. Nutr Cancer 17: 195-201
13. Dardene M 2002 Zinc and immune function. Eur J Clin Nutr 56 (Suppl 3): 20-23
14. Dos UN 2002 A radical approach to cancer. Mod Sci Monit 8: 79-92
15. De Silva DM, Aust SD 1992 Ferritin and ceruloplasmin in oxidative damage, review and recent findings. Can J Physiol Pharmacol 71: 715-720
16. Dhakshinamoorthy S, Long II DJ, Jaiswal AK 2000 Antioxidant regulation of genes encoding enzymes that detoxify xenobiotics and carcinogens. Curr Top Cell Regul 36: 201-216
17. Easmon J 2002 Copper and iron complexes with antitumor activity. Exp Opin Ther Patents 12: 789-818
18. Federico A, Iodice P, Federico P, Del Rio A, Mellone MC, Catalano G, Federico F 2001 Effects of selenium and zinc supplementation on nutritional status in patients with cancer of digestive tract. Eur J Clin Nutr 55: 293-297
19. Fisher LD, Van Belle GW 1993 Biostatistics, a methodology for the health sciences. John Wiley and Sons, New York
20. Frieke C 2000 Function and mechanism of zinc. J Nutr 130: 1437S-1446S
21. Fryer A, Zhao L, Alldersea J, Pearson WR, Strange RC 1993 Use of site-directed mutagenesis of allele-specific PCR primers to identify the GSTM1 A, GSTM1 B, GSTM1 A,B and GSTM1 null polymorphisms at the glutathione S-transfcrase, GSTM1 locus. Biochem J 295: 313-315
22. Ginter E 2000 Recent trends in cancer mortality in the Slovak Republic and in Europe. Neoplasma 47: 68-72
23. Goodman GE, Schaffer S, Bankson DD, Hughes MP, Omenn GS, CARET Co-Investigators 2001 Predictors of serum selenium in cigarette smokers and the lack of association with lung and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 10: 1069-1076
24. Grinberg-Funes R, Singh VN, Perera FP, Bell DA, Young TL, Dickey C 1994 Polycyclic aromatic hydrocarbon-DNA adducts in smokers and their relationship to micronutrient levels and the glutathione S-transferase M1 genotype. Carcinogencsis 15: 2449-2454
25. Gsur A, Haidinger G, Hollaus P, Herbacek I, Madersbacher S, Trieb K, Pridun N, Mohn-Staudner A, Vetter N, Vutuc C, Micksche M 2001 Genetic polymorphism of CYP1A1 and GSTM1 lung cancer risk. Anticancer Res 21: 2237-2242
26. Hayes JD, Strange A 1995 Invited commentary potential contribution of the glutathione S-transferase supergene family to resistance to oxidative stress. Free Radic Res 22: 193-207
27. Hecht SS 1999 Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 91: 1194-1210
28. Helzlsouer KJ, Alberg AJ, Norkus EP, Morris JS, Hoffman SC, Comstock GW 1996 Prospective study of serum micronutrients and ovarian cancer. J Natl Cancer Inst 88: 32-37
29. Hirvonen A, Husgafvel-Pursiainen K, Anttila S, Vainio H 1993 The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis 14: 1479-1481
30. Hou SM, Falt S, Nyberg F 2001 Glutathione S-transferase T1-null genotype interacts synergistically with heavy smoking on lung cancer risk. Environ Mol Mutagen 38: 83-86
31. Inskip A, Elexperu-Camiruaga J, Buxton N, Dias PS, MacIntosh J, Campbell D, Jones PW, Yengi L, Talbot JA, Strange RC, Fryer AA 1995 Identification of polymorphism at the glutathione transferase GSTM3 locus: evidence for linkage with GSTM1*A. Biochem J 312: 713-716
32. Ip C, Lisk DJ 1997 Modulation of phase I and phase II xenobiotic-metabolizing enzymes by selenium-enriched garlic in rats. Nutr Cancer 28: 184-188
33. Ip C 1998 Lessons from basic research in selenium and cancer prevention. Am Soc Nutr Sci Crit Rev 128: 1845-1854
34. Ketterer B 1998 Glutathione S-transferases and prevention of cellular free radical damage. Free Radic Res 28: 647-658
35. Kihara M, Kihara M, Noda K 1999 Lung cancer risk of the GSTM1 null genotype is enhanced in the presence of the GSTP1 mutated genotype in male Japanese smokers. Cancer Lett 137: 53-60
36. Kim YS, Milner J 2001 Molecular targets for selenium in cancer prevention. Nutr Cancer 40: 50-54
37. Klauning JE, Xu Y, Isenberg JS, Bachowski S, Kolaja KL, Jiang J, Stevenson DE, Walborg Jr EF 1998 The role of oxidative stress in chemical carcinogenesis. Environ Health Perspect 106 (Suppl 1): 289-295
38. Knekt P, Mariniemi J, Teppo L, Heliövaara M, Aromaa A 1998 Is low selenium status a risk factor for lung cancer? Am J Epidemiol 148: 975-148
39. Kretz-Remy C, Mehlen P, Mirault ME, Arrigo AP 1996 Inhibition of 1κB-α phosphorylation and degradation and subsequent NF-κB activation by glutathione peroxidase overexpression. J Cell Biol 133: 1083-1093
40. Linder MC 2001 Copper and genomic stability in mammals. Mutat Res 475: 141-152
41. Maehira F, Luyo GA, Miyagi I, Oshiro M, Yamane N, Kuba M, Nakazato Y 2002 Alterations of serum selenium concentrations in the acute phase of pathological conditions. Clin Chim Acta 316: 137-146
42. Malvy DJM, Burtschy B, Arnaud J, Sammelet D, Leverger G, Dostalova L, Drucker J, Amedee-Manesme O 1993 Serum beta-carotene and antioxidant micronutrients in children with cancer. Int J Epidemiol 22: 761-771
43. Margalioth EJ, Udassin R, Cohen C, Maor J, Anteby SO, Schenker JG 1987 Scrum copper level in gynecologic malignancies. Am J Obstet Gynecol 157: 93-96
44. Monks TJ, Anders MW, Dekant W, Stevens JL, Lau SS, Van Bladeren PJ 1990 Glutathione conjugate mediated toxicities. Toxicol Appl Pharmacol 106: 1-19
45. Mullauer L, Gruber P, Sebinger D, Buck J, Wohlfart S, Chott A 2001 Mutations in apoptosis genes: a pathogenetic factor for human disease. Mutat Res 488: 211-231
46. Neve J, Chamart S, Molle L 1987 Optimization of direct procedure for the determination of selenium in plasma and erythrocytes using Zeeman effect atomic absorption spectroscopy. In: Bratter P, Schramel P (eds) Trace Elemenents Analytical Chemistry in Medicine and Biology (Vol 4). Walter de Gruyter, Berlin, pp 349-358
47. Nordberg J, Amer ESJ 2001 Reactive oxygen species, antioxidants and mammalian thioredoxin system. Free Radic Biol Med 31: 1287-1312
48. Overvad K, Wang DY, Olsen J, Allen DS, Thorling EB, Bulbrook RD, Hayward JL 1993 Copper in human mammary carcinogenesis: a case-control study. Am J Epidemiol 137: 409-414
49. Parkin DM, Bray FI, Devesa SS 2001 Cancer burden in the year 2000. The global picture. Eur J Cancer 37: S4-S66
50. Pawlowicz Z, Zachara BA, Trafikowska U, Nowicki A 1993 Low selenium level and glutathione peroxidase activity in blood of patients with gastrointestinal cancer (in Polish) Pol Tyg Lek 48: 25-26
51. Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, Kettere B, Taylor JB 1994 Human glutathione S-transferase Theta (GSTT1): cDNA cloning and the characterization of genetic polymorphism, Biochem J 300: 271-276
52. Piccinini L, Borella P, Bargellini A, Incerti Medici C, Zoboli A 1996 A case-control study on selenium, zinc, copper in plasma and hair of subjects affected by breast and lung cancer. Biol Trace Elem Res 51: 23-30
53. Platz EA, Helzisouer KJ 2001 Selenium, zinc and prostate cancer. Epidemiol Rev 23: 93-101
54. Prasad AS 1995 Zinc; an overview. Nutrition 11: 93-99
55. 2+-induced apoptosis in cancer cells. Free Radic Biol Med 32: 431-445
56. Radzikowska E, Glaz P, Roszkowski K 2002 Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20,561 cases. Ann Toxicol 13: 1087-1093
57. Rink L, Gabriel P 2000 Zinc and immune system. Proc Nutr Soc 59: 541-552
58. Ryberg D, Skaug V, Hewer A, Phillips DH, Harries LW, Wolf CR, Ogreid D, Ulvik A, Vu P, Haugen A 1997 Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogcnesis 12: 1285-1289
59. Scheffe H 1959 The analysis of variance. Wiley, New York
60. Seidegard J, Vorachek WR, Pero RW, Pearson WR 1988 Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci USA 85: 7293-7297
61. Shields PG, Harris CC 2000 Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J Clin Oncol 18: 2309-2315
62. Sinha R, Caporaso N 1999 Diet, genetic susceptibility and human cancer etiology. J Nutr, Suppl 2S, 129: 556-559
63. Sohn OS, Fiala ES, Upadhyaya P, Chae YH, El-Bayoumy K 1999 Comparative effects of phenylenebis(methylene)selenocyanate isomers on xenobiotic metabolizing enzymes in organs of female CD rats. Carcinogenesis 20: 615-621
64. Spjotvoll E, Stoline MR 1973 An extension of the T-method of multiple comparison to include the cases with unequal sample sizes. J Am Statist Assoc 68: 976-978
65. Sun Y 1990 Free radicals, antioxidant enzymes, and carcinogenesis. Free Radic Biol Med 8: 583-599
66. To-Figueras J, Gene M, Gomez-Catalan J, Pique E, Borrego N, Marfany G 2000 Polymorphism of glutathione S-transferase M3: interaction with glutathione S-transferase M1 and lung cancer susceptibility. Biomarkers 5: 73-80
67. Tolando R, Jovanovic A, Brigelius-Flohe R, Ursini F, Maiorino M 2000 Reactive oxygen species and pro-inflammatory cytokine signalling in endothelial cells: effect of selenium supplementation. Free Radic Biol Med 28: 979-986
68. Upham BL, Wagner JG 2001 Toxicant-induced oxidative stress in cancer. Toxicol Sci 64: 1-3
69. Van den Berg R, Haenen GRMM, Van den Berg H, Bast A 2001 Transcription factor NF-κB as a potential biomarker for oxidative stress. Br J Nutr 86 (Suppl 1): 121-127
70. Van der Vliet A, Cross CE 2000 Oxidants, nitrosants, and the lung. Am J Med 109: 398-421
71. Wasowicz W, Gromadzinska J, Sklodowska M, Wolkanin P, Zambrano Quispe O, Pluzanska A 1993 Selenium concentrations and glutathione peroxidase activities in blood of breast cancer women. Trace Elem Med 10: 168-172
72. Wasowicz W, Kantorski J, Perek D, Popadiuk S 1989 Concentration of zinc and zinc-copper superoxide dismutase activity in red blood cells in normals and children with cancer. J Clin Chem Clin Biochem 27: 413-418
73. Wasowicz W, Reszka E, Gromadzinska J, Rydzynski K 2003 The role of essential elements on oxidative stress. Comm Toxicol 9: 39-48
74. Watson MA, Stewart RK, Smith GBJ, Massey TE, Bell DA 1998 Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 19: 275-280
75. Weisburger JH 1999 Antimutagens, anticarcinogens, and effective worldwide cancer prevention. J Environ Pathol Toxicol Oncol 18: 85-93
76. Witkowski K, Kozlowski A, Pardela M, Piecuch J, Walichiewicz P 1993 Copper level in plasma and tissues of patients with oesophageal and colon carcinoma (in Polish). Wiadom Lek 46: 15-16
77. Zachara BA, Marchaluk-Wisniewska E, Maciag A, Peplinski J, Skokowski J, Lambrecht W 1997 Decreased selenium concentration and glutathione peroxidase activity in blood and increase of these parameters in malignant tissue of lung cancer patients. Lung 175: 321-332
78. Zhong W, Oberley TD 2001 Redox-mediated effects of selenium on apoptosis and cell cycle in the LNCaP human prostate cancer cell line. Cancer Res 61: 7071-7078